Could a home device spot sleep apnea in people on narcotics?

NCT ID NCT03670914

Completed Diagnosis Sponsor: Kaiser Permanente Source: ClinicalTrials.gov ↗

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study tests whether a wearable home sleep apnea device called WatchPAT200 can accurately detect central sleep apnea in people who take narcotic medications. Participants wear the device during an overnight lab sleep study, and results are compared to the standard in-lab test. If the device works well, it could offer a more convenient way to diagnose sleep-related breathing problems in this group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: WatchPAT200 home sleep apnea test device
What this could lead to: If accurate, this could allow people on narcotics to be tested for sleep apnea at home instead of in a lab.
What could go wrong: This is a small, early study with only 24 participants, so results may not apply to everyone. The device may not detect all types of breathing events accurately.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CENTRAL SLEEP APNEA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

central sleep apnea syndrome opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CENTRAL SLEEP APNEA NARCOTIC USE

Contacts and locations

Show contact details

Locations

Sleep Center; San Bernardino County Medical Center, Kaiser Permanente

Fontana, California, 92335, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.